首页> 外国专利> AQUEOUS SUSPENSION COMPOSITIONS, FORMULATIONS, AND WATER DISPERSIBLE DRY COMPOSITIONS COMPRISING 16ALPHA-BROMO-3BETA-HYDROXY-5ALPHA-ANDROSTAN-17-KETONE AND HYDRATES, DERIVATIVES, AND ANALOGS THEREOF

AQUEOUS SUSPENSION COMPOSITIONS, FORMULATIONS, AND WATER DISPERSIBLE DRY COMPOSITIONS COMPRISING 16ALPHA-BROMO-3BETA-HYDROXY-5ALPHA-ANDROSTAN-17-KETONE AND HYDRATES, DERIVATIVES, AND ANALOGS THEREOF

机译:包含16Alpha-Bromo-3beta-羟基-5Alpha-androstan-17-酮和水合物,衍生物及其类似物的悬浮液组合物,制剂和水分散性干燥组合物

摘要

Method of treating a subject in need of a treatment for modulating immune system or anti-microbial infection, comprising administering a stable aqueous suspension formulation, which may be reconstituted from a water dispersible dry composition, comprising compound of Formula I in the form of particles stabilized in an aqueous suspension. It causes little or no injection site irritation and has superior properties over non-aqueous formulations. It stimulates autophagy, enhance innate immunity, down-regulates unproductive inflammation and exerts a Th1 immune bias. It demonstrates better efficacy in both in vitro and in vivo models.; embedded image
机译:治疗需要治疗用于调节免疫系统或抗微生物感染的受试者的方法,包括施用稳定的水性悬浮制剂,其可以由水分散性干燥组合物重构,所述水分散性干燥组合物包含稳定的颗粒形式的式I化合物在水性悬浮液中。它导致注射部位刺激很少或没有注射部位刺激,并且在非水性制剂上具有优异的性能。它刺激自噬,增强先天免疫力,降低不调节的不生产性炎症并施加Th1免疫偏差。它在体外和体内模型中表现出更好的疗效。 <化学ID =“Chem-US-00001”> “嵌入式图像”文件=“US20210061846A1-20210304-C00001.GIF”他=“34.21mm”ImgContent

著录项

  • 公开/公告号US2021061846A1

    专利类型

  • 公开/公告日2021-03-04

    原文格式PDF

  • 申请/专利权人 SD CHEM INC.;

    申请/专利号US202017098307

  • 发明设计人 YU GE;

    申请日2020-11-13

  • 分类号C07J1;A61K9;A61K31/5685;A61P1;A61P31/06;A61P37/06;A61P3/10;A61P35;A61K9/19;A61K47/34;A61K47/38;A61P11/06;

  • 国家 US

  • 入库时间 2022-08-24 17:30:25

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号